What Researchers Did
Researchers systematically evaluated the efficacy of hyperbaric oxygen therapy (HBOT) as an adjunct treatment for sleep disorders in patients with Parkinson's disease through a meta-analysis of randomized controlled trials.
What They Found
This meta-analysis, including seven randomized controlled trials with 461 participants, found that adding hyperbaric oxygen therapy significantly improved sleep efficiency (MD = 15.26, 95% CI [10.89, 19.63]). The findings support HBOT as an effective adjunct therapy for managing sleep disorders in Parkinson's disease patients.
What This Means for Canadian Patients
Canadian patients with Parkinson's disease experiencing sleep disturbances may find hyperbaric oxygen therapy to be a beneficial adjunct treatment option. They should discuss the potential benefits and availability of HBOT with their healthcare providers to determine if it is suitable for their condition.
Canadian Relevance
This study has no direct Canadian connection as it did not involve Canadian participants, researchers, or institutions.
Study Limitations
The limitations of this meta-analysis may include potential heterogeneity among the included studies or publication bias, despite assessments.